[New antiretroviral drug classes in HIV therapy]

MeSH terms

• Anti-HIV Agents / adverse effects
• Anti-HIV Agents / classification
• Anti-HIV Agents / therapeutic use*
• CCR5 Receptor Antagonists
• Cyclohexanes / adverse effects
• Cyclohexanes / therapeutic use
• HIV Fusion Inhibitors / adverse effects
• HIV Fusion Inhibitors / therapeutic use
• HIV Infections / drug therapy*
• HIV Infections / virology
• HIV Integrase Inhibitors / adverse effects
• HIV Integrase Inhibitors / therapeutic use
• HIV-1 / drug effects*
• Humans
• Maraviroc
• Piperazines / adverse effects
• Piperazines / therapeutic use
• Pyrimidines / adverse effects
• Pyrimidines / therapeutic use
• Pyrrolidinones / adverse effects
• Pyrrolidinones / therapeutic use
• Quinolones / adverse effects
• Quinolones / therapeutic use
• Raltegravir Potassium
• Succinates / adverse effects
• Succinates / therapeutic use
• Triazoles / adverse effects
• Triazoles / therapeutic use
• Triterpenes / adverse effects
• Triterpenes / therapeutic use
• Viral Load